Non-invasive vagal nerve stimulation to treat disorders

US9415219B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9415219-B2
Application numberUS-201514660136-A
CountryUS
Kind codeB2
Filing dateMar 17, 2015
Priority dateMar 20, 2009
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices, systems and methods are disclosed for treating a variety of diseases and disorders that are primarily or at least partially driven by an imbalance in neurotransmitters in the brain, such as asthma, COPD, depression, anxiety, epilepsy, fibromyalgia, and the like. The invention involves the use of an energy source comprising magnetic and/or electrical energy that is transmitted non-invasively to, or in close proximity to, a selected nerve to temporarily stimulate, block and/or modulate the signals in the selected nerve such that neural pathways are activated to release inhibitory neurotransmitters in the patient's brain.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of treating a disorder in a patient, the method comprising: positioning a device adjacent to a skin surface of the patient; generating, via the device, a signal comprising one or more electrical impulses; and transmitting, via the device, the one or more electrical impulses to a nerve in the patient, wherein the one or more electrical impulses comprises bursts of pulses with a silent inter-burst interval between each of the bursts, wherein each of the bursts and the silent inter-burst interval repeats from about 3 Hz to about 100 Hz, wherein each of the pulses has a duration from about 50 microseconds to about 1000 microseconds, wherein each of the bursts comprises from about 2 pulses to about 20 pulses. 2. The method of claim 1 , wherein the one or more electrical impulses generates an electric field at a vagus nerve of the patient above a threshold for generating action potentials within A and B fibers of the vagus nerve and below a threshold for generating action potentials within C fibers of the vagus nerve. 3. The method of claim 2 , wherein the electric field is between about 10 to 600 V/m. 4. The method of claim 1 , wherein the one or more electrical impulses is sufficient to generate an electric field gradient at a vagus nerve of the patient, wherein the electric field gradient is greater than about 2 V/m/mm. 5. The method of claim 4 , wherein the electric field is less than 100 V/m. 6. The method of claim 4 , wherein the electric field is above a threshold for generating action potentials within A fibers of the vagus nerve and below a threshold for generating action potentials within B fibers of the vagus nerve. 7. The method of claim 4 , wherein the electric field is below a threshold for generating action potentials within A-delta fibers of the vagus nerve. 8. The method of claim 4 , wherein the electric field is not sufficient to produce a movement of a skeletal muscle of the patient. 9. The method of claim 1 , wherein the one or more electrical impulses is constrained from modulating one or more nerves in a region between the skin surface and a vagus nerve of the patient. 10. The method of claim 1 , wherein the pulses are full sinusoidal waves. 11. A device for treating a disorder in a patient, the device comprising: a housing comprising a contact surface configured to contact an outer skin surface of the patient; and an energy source coupled to the housing, wherein the energy source is configured to transmit an electric current through the outer skin surface of the patient to a nerve within the patient, wherein the electric current comprises a signal comprising bursts of pulses with a silent inter-burst interval between each of the bursts, wherein each of the bursts and the silent inter-burst interval repeats from about 3 Hz to about 100 Hz, wherein each of the pulses has a duration from about 50 microseconds to about 1000 microseconds, wherein each of the bursts comprises from about 2 pulses to about 20 pulses. 12. The device of claim 11 , wherein the electric current is sufficient to generate an electric field at a vagus nerve of the patient above a threshold for generating action potentials within A and B fibers of the vagus nerve and below a threshold for generating action potentials within C fibers of the vagus nerve. 13. The device of claim 11 , wherein the energy source is enclosed within the housing. 14. The device of claim 12 , wherein the electric field is between about 10 to 600 V/m. 15. The device of claim 11 , wherein the electric current is sufficient to generate an electric field gradient at a vagus nerve of the patient, wherein the electric field gradient is greater than about 2 V/m/mm. 16. The device of claim 15 , wherein the electric field is less than 100 V/m. 17. The device of claim 11 , wherein the energy source comprises a signal generator and one or more electrodes coupled to the signal generator within the housing. 18. The device of claim 17 , further comprising: a conducting medium positioned within the housing between the one or more electrodes and the contact surface. 19. The device of claim 11 , wherein the energy source comprises a battery. 20. The device of claim 11 , wherein the housing is a handheld device configured to contact the outer skin surface of the patient.

Assignees

Inventors

Classifications

  • specified by the stimulation parameters · CPC title

  • Measuring devices for evaluating the respiratory organs · CPC title

  • using magnetic fields produced by coils, including single turn loops or electromagnets (A61N2/12 takes precedence) · CPC title

  • for pain treatment or analgesia · CPC title

  • Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath (A61B5/083, A61B5/091 take precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9415219B2 cover?
Devices, systems and methods are disclosed for treating a variety of diseases and disorders that are primarily or at least partially driven by an imbalance in neurotransmitters in the brain, such as asthma, COPD, depression, anxiety, epilepsy, fibromyalgia, and the like. The invention involves the use of an energy source comprising magnetic and/or electrical energy that is transmitted non-invas…
Who is the assignee on this patent?
Electrocore Llc
What technology area does this patent fall under?
Primary CPC classification A61N1/36034. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).